SCHEMBL2083520

SCHEMBL2083520

Cc1cc(F)cnc1CC(CCCN)NCc1ncccc1C(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 6/20 0.35
AGBL2 Q5U5Z8 1/20 0.32
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
CYP1A2 P05177 2/20 0.31
ABCB11 O95342 1/20 0.31
ESR1 P03372 1/20 0.31
PGR P06401 1/20 0.31
ADRB2 P07550 1/20 0.31
CHRM2 P08172 1/20 0.31
ADRB1 P08588 1/20 0.31
HTR1A P08908 1/20 0.31
ADRA2A P08913 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
NQO2 P16083 1/20 0.31
MAOA P21397 1/20 0.31
PTGS1 P23219 1/20 0.31
SLC6A2 P23975 1/20 0.31
MAOB P27338 1/20 0.31
PDE4A P27815 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2082834 0.92 CXCR4 (0.33) CXCR4HSP90AA1HSP90AB1CYP1A2ABCB11
SCHEMBL2082894 0.90 CXCR4 (0.42) CXCR4HSP90AA1HSP90AB1CYP1A2ABCB11
SCHEMBL2085658 0.88 CXCR4 (0.33) CXCR4HSP90AA1HSP90AB1CYP1A2ABCB11
SCHEMBL2080684 0.83 CXCR4 (0.39) CXCR4HSP90AA1HSP90AB1CYP1A2ABCB11
SCHEMBL2084457 0.82 CXCR4 (0.35) CXCR4HSP90AA1HSP90AB1CYP1A2ABCB11
SCHEMBL2085865 0.81 CXCR4 (0.33) CXCR4HSP90AA1HSP90AB1CYP1A2ABCB11
SCHEMBL4214955 0.78 CXCR4 (0.41) CXCR4HSP90AA1HSP90AB1CYP1A2ABCB11
SCHEMBL2085140 0.78 AGBL2 (0.36) CXCR4AGBL2CYP1A2MAOAMAOB
SCHEMBL2082171 0.77 ADORA2A (0.41) CXCR4HSP90AA1HSP90AB1CHRM2MAOA
SCHEMBL2084704 0.77 CXCR4 (0.41) CXCR4HSP90AA1HSP90AB1CYP1A2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7863293-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2011-01-04 US claimed
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED CORPORATION (CA) 2008-10-16 US claimed
US-7291631-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2007-11-06 US claimed
EP-1613613-B1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS GENZYME CORP (US) 2021-06-02 EP disclosed
US-7863293-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2011-01-04 US disclosed
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED CORPORATION (CA) 2008-10-16 US disclosed
US-7291631-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2007-11-06 US disclosed
US-20040209921-A1 CXCR4 chemokine receptor binding comounds ANORMED CORPORATION (CA) 2004-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040209921-A1 CXCR4 chemokine receptor binding comounds CXCR4, CXCR1, CXCR3 CXCR4 1/4885AGBL2 3707/4885HSP90AA1 2609/4885
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS CXCR4, CXCR1, CXCR3 CXCR4 1/4885AGBL2 3675/4885HSP90AA1 2463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.